A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers

NCT06611345 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancers (BTC)

Interventions

DEVICE: Tumor Treating Fields
DRUG: Durvalumab
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Jiangsu Healthy Life Innovation Medical Technology Co., Ltd

Collaborators

[object Object]